# Cisatracurium

## Nimbex inj 10mg/5mL

| TAH Drug Code      | [INIMB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=INIMB)                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Muscle relaxation during surgical procedures eg cardiac surgery, other procedures & in intensive care. Adjunct to general anesth or sedation in the ICU, to relax skeletal muscles & to facilitate tracheal intubation & mechanical ventilation.                                                                                                                       |
| Dosing             | IV bolus Tracheal intubation: Adult: Initially 0.15 mg/kg over 5-10 seconds. Maintenance: 0.03 mg/kg. Children 1 month-12 years same as adult dose. Maintenance: 0.02 mg/kg. IV infusion for maintenance of neuromuscular blockade: Adult & children 1 month-12 years: 3 mcg/kg/min initially and 1-2 mcg/kg/min thereafter to maintain 89-99% neuromuscular blockade. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to cisatracurium besylate or any component of the formulation; use of the 10 mL multiple-dose vials in premature infants (formulation contains benzyl alcohol)                                                                                                                                                                                        |
| Adverse Effects    | Bradycardia, hypotension. Rarely cutaneous flushing, bronchospasm, rash.                                                                                                                                                                                                                                                                                               |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cisatracurium-drug-information)                                                                                                                                                                                                                                                                                           |

## Winbest inj 10mg/5mL

| TAH Drug Code      | [IWINB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IWINB)                                                                                                                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | A highly selective and competitive non-depolarizing neuromuscular blocker. As an adjunct to general anesthesia in surgery or in ICU settings to relax skeletal muscles, facilitate tracheal intubation, and assist with ventilator coordination.                                                                                                                           |
| Dosing             | Tracheal Intubation: Adults: 0.15 mg/kg over 5-10 seconds. Range: 0.1-0.4 mg/kg. Maintenance dose: 0.03 mg/kg. Children (1 month to 12 years): 0.15 mg/kg over 5-10 seconds. Range: 0.1-0.4 mg/kg. Maintenance dose: 0.02 mg/kg. For adults in the ICU: IV bolus or infusion. Infusion rate: 3 mcg/kg/min (0.18 mg/kg/hr). Range: 0.5-10.2 mcg/kg/min (0.03-0.6 mg/kg/hr). |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Hypersensitivity to cisatracurium, atracurium, benzenesulphonic acid, or any component of the product.                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Serious: Bradyarrhythmia (0.4%), Hypotension (0.2%), Metabolic acidosis, Anaphylaxis, Central nervous system depression, Paralysis, Seizure, Bronchospasm (0.2-1.5%), Gasping for breath.                                                                                                                                                                                  |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cisatracurium-drug-information)                                                                                                                                                                                                                                                                                               |

